BVS · Bioventus Inc
United States · RS rating 96 · As of 2026-10-14
| Price | 13.50 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 96 / 87 / 84 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 49 / 55 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | -81.0% |
| Sales growth Q/Q | +13.9% |
| Distance from 52-week high | +11.5% |
| Market cap (USD) | $656.8M |